$STAA·8-K

STAAR SURGICAL CO · Mar 3, 4:05 PM ET

STAAR SURGICAL CO 8-K

Research Summary

AI-generated summary

Updated

STAAR Surgical Reports Results for Quarter and Year Ended Jan 2, 2026

What Happened

  • STAAR Surgical Company announced its financial results for the quarter and fiscal year ended January 2, 2026 in a press release dated March 3, 2026.
  • The company scheduled a conference call and webcast for March 3, 2026 at 5:30 p.m. Eastern / 2:30 p.m. Pacific for management to discuss the quarterly results; speakers include the company’s Interim Co-Chief Executive Officers — one serving as President and Chief Operating Officer and the other serving as Chief Financial Officer.
  • The press release and the shareholder letter for the call are furnished as Exhibits 99.1 and 99.2 to the Form 8-K. The materials are furnished (not “filed”) and therefore are not subject to Section 18 liability or automatically incorporated by reference into other filings.

Key Details

  • Filing date: March 3, 2026 (Form 8-K).
  • Reporting period: quarter and year ended January 2, 2026.
  • Investor event: conference call/webcast on March 3, 2026 at 5:30 p.m. ET / 2:30 p.m. PT.
  • Exhibits: 99.1 (press release) and 99.2 (shareholder letter) provided with the 8-K.

Why It Matters

  • The earnings release and management call provide the company’s latest quarterly results and commentary from interim leadership (including the CFO), which investors use to assess recent revenue, profitability, and operating trends.
  • The timing and availability of the press release and shareholder letter give investors and analysts immediate access to the company’s reported financial performance and management’s explanations, which can influence trading and investment decisions.
  • Note the company’s legal disclaimer that these materials are furnished, not filed, which affects how the information can be used in future SEC filings.

Loading document...